🇺🇸 FDA
Patent

US 10240153

Organic compositions to treat APOC3-related diseases

granted A61KA61K31/713

Quick answer

US patent 10240153 (Organic compositions to treat APOC3-related diseases) held by Arrowhead Pharmaceuticals, Inc. expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arrowhead Pharmaceuticals, Inc.
Grant date
Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/713